{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:45Z","timestamp":1786372965592,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.2215\/cjn.02181205","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T20:44:13Z","timestamp":1154551453000},"page":"1100-1107","source":"Crossref","is-referenced-by-count":30,"title":["TNF-\u03b1 Bioactivity-Inhibiting Therapy in ANCA-Associated Vasculitis"],"prefix":"10.2215","volume":"1","author":[{"given":"Dennis","family":"Huugen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200609000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:23Z","timestamp":1786369223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200609000-00029"}},"subtitle":["Clinical and Experimental Considerations"],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02181205","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}